Micrologix biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Graham Dellaire who wrote (662)	2/16/2000 11:31:00 AM
From: Sean Janzen	of 792

Graham Could you add Inflazyme pharmaceuticals (IZP on Toronto) to your Canadian Biotech Portfolio? The stock is up 400% in the last 4 months. Management is doing the dog & pony show in the US. Look for an IPO onto Nasdaq with assistance from Goldman Sachs. I think IZP could double or triple before year end. Does anyone know if MBI has enough cash to advance MBI 226 through Phase III? The warrants from the last financing should be exercisable soon. This will add $9 Million to MBI's coffers. We have seen some low ball predictions for MBI. I think MBI could trade at US$15+ after they can get MBI 226 to market(My 18 month target).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next